Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥197,337.13, with a 24-hour trading volume of ¥298.45B. The asset's market cap is ¥175.97T, after moving -1.32% in the last day.
Tokenized Eli Lilly And Co is trading at ¥197,748.35, with a tokenized market cap of ¥7.63B and a 24-hour trading volume of ¥356.81M. The tokenized asset has moved -0.06% in the past 24 hours.